Martin Shkreli: A Pharmecuetical Con Artist At It Again
Start writing a post
Politics and Activism

Martin Shkreli: A Pharmecuetical Con Artist At It Again

16
Martin Shkreli: A Pharmecuetical Con Artist At It Again

Martin Shkreli, a pharmaceutical con artist, was taken into custody this past week with a 5 million dollar bond. Though Shkreli is known for price gouging vital drugs, he is being charged for repeatedly losing money for investors and lying to them about it, illegally taking assets from one of his companies to pay off debtors in another.

“Shkreli essentially ran his company like a Ponzi scheme where he used each subsequent company to pay off defrauded investors from the prior company,” said Brooklyn U.S. Attorney Robert Capers, at a press conference.

The 32 year old has become infamous within the pharmaceutical drug industry for raising prices more than 55 times for Daraprim in September. Prices went from $13.50 per pill to $750. This drug is the primary treatment for a parasitic condition, more commonly known as toxoplasmosis, which can be deadly for unborn babies and patients with compromised immune systems including those with HIV or cancer. Turing Pharmaceuticals AG, Shkreli's company, bought the drug, moved it to a closed distribution system and began making the cost skyrocket.

When he first started getting criticism for the price gouge, he said he would lower the prices. Then he retracted his statements. Hillary Clinton tried interfering last month to get him to cut the cost, but he responded to her with a tweet reading “lol.”

This month at a Forbes summit in New York, Shkreli was casual wearing a hooded sweatshirt where he said if he could have done it over, “I probably would have raised the price higher,” and going on to say, “My investors expect me to maximize profits.”

Before 23 years old, Shkreli was managing hedge fund Elea Capital in New York and lost everything in 2007. Later, in 2010, he lost his clients' $3 million investment in MSMB Capital, his newer fund.

Shkreli's infamous business decisions only furthered when he bet shares of Orexigen Therapeutics Inc. in 2011, where it fell and ended up owing $7 million to his Merrill Lynch, his broker, according to authorities. Shkreli wasn't able to pay his debt extinguished it with a $1.35 million settlement.

Shkreli has many more accusations being thrown at him, with involvement in many other scandals. Let's hope the story of Martin Shkreli has a happy ending and those who he's been benefitting from get justice.

Report this Content
This article has not been reviewed by Odyssey HQ and solely reflects the ideas and opinions of the creator.
Student Life

Waitlisted for a College Class? Here's What to Do!

Dealing with the inevitable realities of college life.

53678
college students waiting in a long line in the hallway
StableDiffusion

Course registration at college can be a big hassle and is almost never talked about. Classes you want to take fill up before you get a chance to register. You might change your mind about a class you want to take and must struggle to find another class to fit in the same time period. You also have to make sure no classes clash by time. Like I said, it's a big hassle.

This semester, I was waitlisted for two classes. Most people in this situation, especially first years, freak out because they don't know what to do. Here is what you should do when this happens.

Keep Reading...Show less
a man and a woman sitting on the beach in front of the sunset

Whether you met your new love interest online, through mutual friends, or another way entirely, you'll definitely want to know what you're getting into. I mean, really, what's the point in entering a relationship with someone if you don't know whether or not you're compatible on a very basic level?

Consider these 21 questions to ask in the talking stage when getting to know that new guy or girl you just started talking to:

Keep Reading...Show less
Lifestyle

Challah vs. Easter Bread: A Delicious Dilemma

Is there really such a difference in Challah bread or Easter Bread?

34538
loaves of challah and easter bread stacked up aside each other, an abundance of food in baskets
StableDiffusion

Ever since I could remember, it was a treat to receive Easter Bread made by my grandmother. We would only have it once a year and the wait was excruciating. Now that my grandmother has gotten older, she has stopped baking a lot of her recipes that require a lot of hand usage--her traditional Italian baking means no machines. So for the past few years, I have missed enjoying my Easter Bread.

Keep Reading...Show less
Adulting

Unlocking Lake People's Secrets: 15 Must-Knows!

There's no other place you'd rather be in the summer.

957001
Group of joyful friends sitting in a boat
Haley Harvey

The people that spend their summers at the lake are a unique group of people.

Whether you grew up going to the lake, have only recently started going, or have only been once or twice, you know it takes a certain kind of person to be a lake person. To the long-time lake people, the lake holds a special place in your heart, no matter how dirty the water may look.

Keep Reading...Show less
Student Life

Top 10 Reasons My School Rocks!

Why I Chose a Small School Over a Big University.

181699
man in black long sleeve shirt and black pants walking on white concrete pathway

I was asked so many times why I wanted to go to a small school when a big university is so much better. Don't get me wrong, I'm sure a big university is great but I absolutely love going to a small school. I know that I miss out on big sporting events and having people actually know where it is. I can't even count how many times I've been asked where it is and I know they won't know so I just say "somewhere in the middle of Wisconsin." But, I get to know most people at my school and I know my professors very well. Not to mention, being able to walk to the other side of campus in 5 minutes at a casual walking pace. I am so happy I made the decision to go to school where I did. I love my school and these are just a few reasons why.

Keep Reading...Show less

Subscribe to Our Newsletter

Facebook Comments